Barclays’s Vascular Solutions Inc VASC Stock Holding History

Barclays’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,154	Closed	-$64K	–	7224
2016 Q4	$64K	Buy	1,154 +314	+37%	+$16K	﹤0.01%	5013
2016 Q3	$40K	Sell	840 -4,277	-84%	-$199K	﹤0.01%	5116
2016 Q2	$213K	Buy	+5,117	New	+$190K	﹤0.01%	3886
2016 Q1	–	Sell	-9	Closed	–	–	6704
2015 Q4	$0	Sell	9 -81	-90%	-$2.74K	﹤0.01%	7058
2015 Q3	$3K	Sell	90 -2,758	-97%	-$98.8K	﹤0.01%	6279
2015 Q2	$97K	Sell	2,848 -13,666	-83%	-$446K	﹤0.01%	4701
2015 Q1	$496K	Buy	16,514 +15,123	+1,087%	+$434K	﹤0.01%	3616
2014 Q4	$38K	Buy	1,391 +800	+135%	+$21.7K	﹤0.01%	5927
2014 Q3	$14K	Sell	591 -1,865	-76%	-$44.2K	﹤0.01%	6720
2014 Q2	$54K	Buy	2,456 +1,807	+278%	+$39.6K	﹤0.01%	5888
2014 Q1	$17K	Sell	649 -244	-27%	-$6.07K	﹤0.01%	6693
2013 Q4	$21K	Buy	893 +276	+45%	+$5.41K	﹤0.01%	6703
2013 Q3	$10K	Sell	617 -5,033	-89%	-$81.5K	﹤0.01%	6805
2013 Q2	$84K	Buy	+5,650	New	+$88.9K	﹤0.01%	5927

Other funds holding VASC

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Barclays's VASC Position: Q1 2017 in Review

Barclays sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 1,154 shares — an estimated $64K sold.

Barclays first reported a position in VASC in Q2 2013 and held it in 14 quarters. The position peaked at $496K in Q1 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

Barclays reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
Barclays sold 1,154 Vascular Solutions Inc shares in Q1 2017, an estimated $64K.
Barclays first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 14 quarters.
Barclays's Vascular Solutions Inc position peaked at $496K in Q1 2015.
1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.